Alpha Cognition, Inc. Announces Participation in the D. Boral Capital Inaugural Global Conference

Rhea-AI Summary

Alpha Cognition (NASDAQ: ACOG) has announced its upcoming participation in the D. Boral Capital Inaugural Global Conference. The event is scheduled for May 14, 2025, at The Plaza Hotel in New York City.

Company CEO Michael McFadden will be available for one-on-one meetings throughout the conference day from 9:00 A.M. to 3:00 P.M. (ET). Interested parties who wish to schedule meetings with the management team can make arrangements by contacting John Perez at jperez@dboralcapital.com.

This conference participation represents an opportunity for investors and stakeholders to engage directly with Alpha Cognition's leadership and learn more about the company's developments and strategies.

Positive

• CEO participation in high-profile D. Boral Capital Global Conference indicates potential for increased investor visibility

Negative

• None.

Grapevine, Texas--(Newsfile Corp. - April 30, 2025) - Alpha Cognition, Inc. (NASDAQ: ACOG), today announced its participation in the D. Boral Capital Inaugural Global Conference, taking place May 14, 2025, at The Plaza Hotel in New York City.

Michael McFadden, CEO, will be hosting one-on-one meetings on May 14th from 9:00 A.M. to 3:00 P.M. (ET).

To register for one-on-one meetings with management at The Plaza Hotel in New York City, interested parties should contact John Perez at jperez@dboralcapital.com.

About Alpha Cognition, Inc.
Alpha Cognition is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer’s disease for which there are limited or no treatment options. On July 26, 2024, the Company received approval by the FDA of the Company’s New Drug Application (the “NDA”) for ZUNVEYL® (benzgalantamine) previously known as ALPHA-1062 oral tablet formulation for the treatment of mild-to-moderate Alzheimer’s disease. The Company will now focus on the development of commercial manufacturing and commercial sales of ZUNVEYL oral tablet formulation.

About D. Boral Capital

D. Boral Capital LLC is an investment bank headquartered in New York which provides advisory and financing solutions to middle market and emerging growth companies. The Company has a proven track record of offering strategic guidance to clients across the globe in any sector, with access to capital from the USA, Asia, Europe, Middle East, and Latin America.

D. Boral Capital is a leader on Wall Street, having aggregated over $25 billion in capital across approximately 350 transactions through various product types.

For further information:
Alpha Cognition, Inc.
MICHAEL E MCFADDEN
8583444375
mmcfadden@alphacognition.com

Source Alpha Cognition, Inc.

FAQ

When is Alpha Cognition (ACOG) presenting at D. Boral Capital Global Conference 2025?

Alpha Cognition (ACOG) will participate in the D. Boral Capital Global Conference on May 14, 2025, at The Plaza Hotel in New York City, with one-on-one meetings scheduled from 9:00 AM to 3:00 PM ET.

How can investors schedule meetings with Alpha Cognition ACOG at the D. Boral Conference?

Investors can schedule one-on-one meetings with Alpha Cognition's CEO by contacting John Perez at jperez@dboralcapital.com. Meetings will be held at The Plaza Hotel in New York City.

What type of meetings is Alpha Cognition ACOG offering at the D. Boral Conference?

Alpha Cognition is offering one-on-one meetings with CEO Michael McFadden during a six-hour window from 9:00 AM to 3:00 PM ET on May 14, 2025.

Where is the D. Boral Capital Conference with Alpha Cognition ACOG being held?

The D. Boral Capital Inaugural Global Conference featuring Alpha Cognition will be held at The Plaza Hotel in New York City.

Who will represent Alpha Cognition ACOG at the D. Boral Capital Conference?

Michael McFadden, the CEO of Alpha Cognition, will represent the company and host one-on-one meetings at the conference.